Microbiotix, Inc.
- Biotech or pharma, therapeutic R&D
Microbiotix is an ID-focused MA-based biotech. Programs: filociclovir, targeting (i) adenoviral conjunctivitis/EKC (late preclinical); (ii) adenoviral respiratory infections (Phase 1 completed); and (iii) virulence inhibitor targeting HAP/VAP-preclinical.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}